Office of rare diseases neuropathologic criteria for corticobasal degeneration

Journal of Neuropathology and Experimental Neurology

Volumn 61, Issue 11, 2002, Pages 935-946

  Dickson, Dennis W ^a   Bergeron, C ^a   Chin, S S ^a   Duyckaerts, C ^a   Horoupian, D ^a   Ikeda, K ^a   Jellinger, K ^a   Lantos, P L ^a   Lippa, C F ^a   Mirra, S S ^a   Tabaton, M ^a   Vonsattel, J P ^a   Wakabayashi, K ^a   Litvan, I ^a  

^a MAYO CLINIC   (United States)

Author keywords

Astrocytic plaques; Ballooned neurons; Corticobasal degeneration; Gallyas stain; Neurofibrillary degeneration; Tau; Threads

Indexed keywords

BETA CRYSTALLIN;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN ATROPHY; BRAIN BIOPSY; CELL ULTRASTRUCTURE; CLINICAL EXAMINATION; CORTICOBASAL DEGENERATION; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEWY BODY; NEUROFILAMENT; PARKINSONISM; PRIORITY JOURNAL; SILVER STAINING; SUBSTANTIA NIGRA;

EID: 0036841880     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/61.11.935     Document Type: Article

References (86)

1. Rebeiz JJ, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia: A progressive disorder of late adult life. Trans Am Neurol Assoc 1967;92:23-26
2. Dickson DW, Yen SH, Suzuki KI, Davies P, Garcia JH, Hirano A. Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol 1986;71:216-23
3. Paulus W, Selim M. Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol 1990;81:89-94
4. Wang LN, Kowall NW, Richardson EP Jr. Phosphorylated neurofilament epitopes in the achromasic neurons of corticonigral degeneration. Chinese Med J 1991;104:1011-17
5. Lippa CF, Smith TW, Fontneau N. Corticonigral degeneration with neuronal achromasia. A clinicopathologic study of two cases. J Neurol Sci 1990;98:301-10
6. Arima K, Uesugi H, Fujita I, et al. Corticonigral degeneration with neuronal achromasia presenting with primary progressive aphasia: Ultrastructural and immunocytochemical studies. J Neurol Sci 1994;127:186-97
7. Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989;112:1171-92
8. Bergeron C, Pollanen MS, Weyer L, Black SE, Lang AE. Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol 1996;40:893-900
9. Bergeron C, Pollanen MS, Weyer L, Lang AE. Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. J Neuropathol Exp Neurol 1997;56:726-34
10. Bergeron C, Davis A, Lang AE. Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathol 1998;8:355-65
11. Hauw J-J, Daniel SE, Dickson DW, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-19
12. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97-105
13. Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration: Neuropathologic and clinical heterogeneity. Neurology 1997;48:959-69
14. Kertesz A, Martinez-Lange P, Davidson W, Munoz DG. Corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 2000;55:1368-75
15. Ikeda K, Akiyama H, Iritani S, et al. Corticobasal degeneration with primary progressive aphasia and accentuated cortical lesion in superior temporal gyrus: Case report and review. Acta Neuropathol 1996;92:534-39
16. Grimes DA, Lang AE, Bergeron CB. Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 1999;33:1969-74
17. Litvan I, Grimes DA, Lang AE. Phenotypes and Prognosis: Clinicopathologic studies of Corticobasal degeneration. Adv Neurol 2000;82:183-96
18. Boeve BF, Maraganore DM, Parisi JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999;53:795-800
19. Yamauchi H, Fukuyama H, Nagahama Y, et al. Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration. Arch Neurol 1998;55:609-14
20. Uchihara T, Mizusawa H, Tsuchiya K, Kondo H, Oda T, Ikeda K. Discrepancy between tau immunoreactivity and argyrophilia by the Bodian method in neocortical neurons of corticobasal degeneration. Acta Neuropathol 1998;96:553-57
21. Takahashi T, Amano N, Hanihara T, et al. Corticobasal degeneration: Widespread argentophilic threads and glia in addition to neurofibrillary tangles. Similarities of cytoskeletal abnormalities in corticobasal degeneration and progressive supranuclear palsy. J Neurol Sci 1996;138:66-77
22. Matsumoto S, Udaka F, Kameyama M, Kusaka H, Ito H, Imai T. Subcortical neurofibrillary tangles, neuropil threads, and argentophilic glial inclusions in corticobasal degeneration. Clin Neuropathol 1996;15:209-14
23. Ikeda K, Akiyama H, Haga C, Kondo H, Arima K, Oda T. Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy. Neurosci Lett 1994;174:157-59
24. Komori T, Arai N, Oda M, et al. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 1998;96:401-8
25. Horoupian DS, Chu PL. Unusual case of corticobasal degeneration with tau/Gallyas-positive neuronal and glial tangles. Acta Neuropathol 1994;88:592-98
26. Iqbal K, Braak E, Braak H, Zaidi T, Grundke-Iqbal I. A silver impregnation method for labeling both Alzheimer paired helical filaments and their polypeptides separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Neurobiol Aging 1991;12:357-61
27. Feany MB, Dickson DW. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 1995;146:1388-96
28. Iwatsubo T, Hasegawa M, Ihara Y. Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics. Acta Neuropathol 1994;88:129-36
29. Mori H, Nishimura M, Namba Y, Oda M. Corticobasal degeneration: A disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol 1994;88:113-21
30. Wakabayashi K, Oyanagi K, Makifuchi T et al. Corticobasal degeneration: Etiopathological significance of the cytoskeletal alterations. Acta Neuropathol 1994;87:545-53
31. Chin SSM, Goldman JE. Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 1996;55:499-508
32. Feany MB, Dickson DW. Neurodegenerative disorders with extensive tau pathology: A comparative study and review. Ann Neurol 1996;40:139-48
33. Odawata T, Iseki E, Kosaka K, Akiyama H, Ikeda K, Yamamoto T. Investigation of tau-2 positive microglia-like cells in the subcortical nuclei of human neurodegenerative disorders. Neurosci Lett 1995;192:145-48
34. Clark AW, Manz HJ, White CL 3d, Lehmann J, Miller D, Coyle JT. Cortical degeneration with swollen chromatolytic neurons: Its relationship to Pick's disease. J Neuropathol Exp Neurol 1986;45:268-24
35. Kato S, Hirano A, Umahara T, Llena JF, Herz F, Ohama E. Ultrastructural and immunohistochemical studies on ballooned cortical neurons in Creutzfdldt-Jakob disease: Expression of alpha B-crystallin ubiquitin and stress-response protein 27. Acta Neuropathol 1992;84:443-48
36. Lowe J, Effington DR, Lennox G, et al. Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B crystalline. Neuropathol Appl Neurobiol 1992;18:341-50
37. Mori H, Oda M, Mizuno Y. Cortical ballooned neurons in progressive supranuclear palsy. Neurosci Lett 1996;209:109-12
38. Mizutani T, Inose T, Nakajima S, et al. Familial parkinsonism and dementia with ballooned neurons, argyrophilic neuronal inclusions, atypical neurofibrillary tangles, tau-negative astrocytic fibrillary tangles, and Lewy bodies. Acta Neuropathol 1998;95:15-27
39. Smith TW, Lippa CF, de Girolami U. Immunocytochemical study of ballooned neurons in cortical degeneration with neuronal achromasia. Clin Neuropathol 1992;11:28-35
40. Mori H, Oda M. Ballooned neurons in corticobasal degeneration and progressive supranuclear palsy. Neuropathology 1997;17:248-52
41. Halliday GM, Davies L, McRitchie DA, Cartwright H, Pamphlett R, Morris JG. Ubiquitin-positive achromatic neurons in corticobasal degeneration. Acta Neuropathol 1995;90:68-75
42. Constantinidis J, Richard J, Tissot R. Pick's disease histological and clinical correlations. Eur Neurol 1974;11:208-17
43. Dickson DW. Pick's disease. A modern definition. Brain Pathol 1998;8:339-54
44. Bell K, Cairns NJ, Lantos PL. Immunohistochemistry distinguishes between Pick's disease and corticobasal degeneration. J Neurol Neurosurg Psychiatry 2000;69:835-36
45. Tolnay M, Probst A. Ballooned neurons expressing alpha B-crystallin as a constant feature of the amygdala in argyrophilic grain disease. Neurosci Lett 1998;246:165-68
46. Feany MB, Mattiace LA, Dickson DW. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol 1996;55:53-67
47. Mackenzie IR, Hudson LP. Achromatic neurons in the cortex of progressive supranuclear palsy. Acta Neuropathol 1995;90:615-19
48. Togo T, Dickson D. Ballooned neurons in PSP are usually due to concurrent argyrophilic grain disease. Acta Neuropathol 2002;104:53-56
49. Bancher C, Brunner C, Lassmann H, et al. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res 1989;477:90-99
50. Wisniewski HM, Constantinidis J, Weigel J, Bobinski M, Tarnawski M. Neurofibrillary pathology in brains of elderly schizophrenics treated with neuroleptics. Alzheimer Dis & Assoc Disorders 1994;8:211-27
51. Komori T, Arai N, Oda M, et al. Morphologic difference of neuropil threads in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy: A morphometric study. Neurosci Lett 1997;233:89-92
52. Braak H, Braak E, Grundke-Iqbal I, Iqbal K. Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: A third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 1986;65:351-55
53. Yamaguchi H, Nakazato Y, Shoji M, Ihara Y, Hirai S. Ultrastructure of the neuropil threads in the Alzheimer brain: Their dendritic origin and accumulation in the senile plaques. Acta Neuropathol 1990;80:368-74
54. Uchihara T, Mitani K, Mori H, Kondo H, Yamada M, Ikeda K. Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer's disease or progressive supranuclear palsy. Acta Neuropathol 1994;88:379-83
55. Yamada T, McGeer PL. Oligodendroglial microtobular massess: An abnormality observed in some human neurodegenerative diseases. Neurosci Lett 1995;120:163-66
56. Braak H, Braak E. Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol 1989;15:13-26
57. Lantos PL. The definition of multiple system atrophy: A review of recent developments. J Neuropathol Exp Neurol 1998;57:1099-1111.
58. Arima K, Nakamura M, Sunohara N, et al. Ultrastructural characterization of the tau-immunoreactive tubules in the oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy. Acta Neuropathol 1997;93:558-66
59. Ikeda K, Akiyama H, Kondo H, et al. Thorn-shaped astrocytes: Possibly secondarily induced tau-positive glial fibrillary tangles. Acta Neuropathol 1995;90:620-25
60. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991:82:239-59
61. Su M, Yoshida Y, Hirata Y, Satoh Y, Nagata K. Degeneration of the cerebellar dentate nucleus in corticobasal degeneration: Neuropathological and morphometric investigations. Acta Neuropathol 2000;99:365-70
62. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86
63. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 1997;18:S1-S2
64. Gomez-Tortosa E, Newell K, Irizarry MC, Sanders JL, Hyman BT. Alpha-synuclein immunoreactivity in dementia with Lewy bodies: Morphological staging and comparison with ubiquitin immunostaining. Acta Neuropathol 2000;99:352-57
65. Hamilton RL. Lewy bodies in Alzheimer's disease: A neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 2000;10:378-84
66. Vinters HV, Ellis WG, Zarow C, et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 2000;59:931-45
67. Dickson DW, Davies P, Bevona C, et al. Hippocampal sclerosis: A common pathological feature of dementia in very old (≥80 years of age) humans. Acta Neuropathol 1994;88:212-21
68. Di Maria E, Tabaton M, Vigo T, et al. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol 2000;47:374-77
69. Hauw J-J, Daniel SE, Dickson DW, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-19
70. Oyanagi K, Tsuchiya K, Yamazaki M, Ikeda K. Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and parkinsonism-dementia complex of Guam: Specific pathological features. J Neuropathol Exp Neurol 2001;60:393-402
71. Reed LA, Schmidt ML, Wszolek ZK, et al. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ("pallido-ponto-nigral degeneration"). J Neuropathol Exp Neurol 1998;57:588-601
72. Stanford PM, Halliday GM, Brooks WS, et al. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: Expansion of the disease phenotype caused by tau gene mutations. Brain 2000;123:880-93
73. Braak H, Braak E. Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol 1989;15:13-26
74. Jellinger KA. Dementia with grains (argyrophilic grain disease). Brain Pathol 1998;8:377-86
75. Martinez-Lage P, Munoz DG. Prevalence and disease associations of argyrophilic grains of Braak. J Neuropathol Exp Neurol 1997;56:157-64
76. Togo T, Sahara N, Yen S-H, et al. Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 2002;61:547-56
77. Probst A, Tolnay M, Langui D, Goedert M, Spillantini M. Pick's disease: Hyperphosphorylated tau protein segregates to the somatoaxonal compartment. Acta Neuropathol 1996;92:588-96
78. Trojanowski JQ, Dickson D. Update on the neuropathological diagnosis of frontotemporal dementias. J Neuropathol Exp Neurol 2001;60:1123-26
79. Giannakopoulos P, Hof PR, Bouras C. Dementia lacking distinctive histopathology: Clinicopathological evaluation of 32 cases. Acta Neuropathol 1995;89:346-55
80. Ksiezak-Reding H, Morgan K, Mattiace LA, et al. Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol 1994;145:1496-1508
81. Tellez-Nagel I, Wisniewski HM. Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch Neurol 1973;29:324-27
82. Spillantini MG, Bird TD, Ghetti B. Frontotemporal dementia and Parkinsonism linked to chromosome 17: A new group of tauopathics. Brain Pathol 1998;8:387-402
83. Buee L, Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 1999;9:681-93
84. Brown J, Lantos PL, Rossor MN. Familial dementia lacking specific pathological features presenting with clinical features of corticobasal degeneration. J Neurol Neurosurg Psychiatry 1998;65:600-603
85. Baker M, Litvan I, Houlden H, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Molec Gen 1999;8:711-15
86. Houlden H, Baker M, Morris HR, et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 2001;56:1702-6